Literature DB >> 3028823

Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex.

P D Suzdak, G Gianutsos.   

Abstract

Long-term (14 days) treatment of mice with the antidepressant drug imipramine increased the number of GABA-B receptors in the cerebral cortex and also led to an increase in the potentiation of norepinephrine-induced cAMP accumulation by baclofen (a GABA-B agonist) in cortical slices. Chronic baclofen treatment decreased both of these measures. These results suggest that previous evidence of increased GABA-B binding by antidepressants is coupled to a functional increase in adenylate cyclase activity, but that the mechanism responsible for this effect is not due simply to direct GABA-B receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028823     DOI: 10.1016/0014-2999(86)90526-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

Review 1.  Neurochemical and metabolic aspects of antidepressants: an overview.

Authors:  G B Baker; R T Coutts; A J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS.

Authors:  J A Gray; G M Goodwin; D J Heal; A R Green
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks.

Authors:  J A Gray; A R Green
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

4.  Pharmacological and biochemical characteristics of partially purified GABAB receptor.

Authors:  Y Ohmori; K Kuriyama
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

5.  Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.

Authors:  D J McManus; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.

Authors:  D Schneider; E Schlicker; B Malinowska; G Molderings
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

7.  Decreased gamma-aminobutyric acid (GABA) modulatory effect on rat vas deferens neurotransmission after chronic administration of imipramine.

Authors:  G H Strobel; J B Calixto; G Ballejo
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

8.  Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study.

Authors:  John J Mooney; Jacqueline A Samson; Nancy L McHale; Kathleen M Pappalarado; Jonathan E Alpert; Joseph J Schildkraut
Journal:  J Psychiatr Res       Date:  2013-03-13       Impact factor: 4.791

9.  Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.

Authors:  K G Todd; D J McManus; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

10.  N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.